🇺🇸 beta-endorphin immunoreactivity in United States

beta-endorphin immunoreactivity (beta-endorphin immunoreactivity) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

beta-endorphin immunoreactivity in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is beta-endorphin immunoreactivity approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for beta-endorphin immunoreactivity in United States?

Antonio Martín Duce is the originator. The local marketing authorisation holder may differ — check the official source linked above.